Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline for Intravascular Catheter Infections
NCT00419991Phase 4Completed
- Sponsor
- CPL Associates
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tigecycline in Intravascular Catheter-Related Infection, sponsored by CPL Associates. Primary endpoint: Time to bacterial eradication. Started Jan 2007; status: completed.
02
Drugs
tigecycline
03
Conditions
Intravascular Catheter-Related Infection
Beyond the preview
Go deeper on NCT00419991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419991.